The Latest Cardiac and Vascular News
PARIS, May 23, 2018 /PRNewswire/ — Today MicroPort Scientific Corporation (HKSE: 0853) (“MicroPort™”) announced primary endpoint data at 12 months and QCA angiography data at 13 months from its TARGET All-Comers (TARGET AC) trial. The results of the TARGET AC trial demonstrated that vessels treated with the Firehawk sirolimus drug eluting stent […]
SOUTH SAN FRANCISCO, Calif., May 21, 2018 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced that it has commenced a proposed underwritten public offering of 3,750,000 shares of its common stock. All shares of […]
ST. LOUIS, May 22, 2018 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David Fischel, Chairman and Chief Executive Officer, is scheduled to present at the 8th Annual LD Micro Invitational. Mr. Fischel will provide an […]
PARIS, May 22, 2018 (GLOBE NEWSWIRE) — HeartFlow, Inc. today announced new data from the PACIFIC trial showed that the HeartFlow Analysis had the highest diagnostic performance for detecting coronary artery disease (CAD), the most common form of heart disease, when compared to other commonly used non-invasive cardiac tests. Additionally, data from […]
MAASTRICHT, Netherlands, May 22, 2018 /PRNewswire/ — A highly innovative software, developed by Pie Medical Imaging – PMI – B.V. (Esaote Group) will be presented at EuroPCR 2018, the world-leading course in interventional cardiovascular medicine, held in Paris, Palais des Congrès (France) between 22 – 25 May 2018. This software – called CAAS vFFR (Cardiovascular Angiographic Analysis Systems for vessel […]
PARIS, May 22, 2018 /PRNewswire/ — NMT2 announces it will be featured at the 2018 EUROPCR Congress in Paris, France. The annual assembly, which again takes place at the Palace de Congress in Paris from May 22-25, 2018, is the worldwide gathering for in-depth scientific presentations, new innovations, training and reports of clinical data results in the […]
WASHINGTON, May 21, 2018 /PRNewswire/ — An article published in Experimental Biology and Medicine (Volume 243, Issue 8, May, 2018) identifies a new approach for treating cardiac arrythmias (http://journals.sagepub.com/doi/full/10.1177/1535370218769420). The study, led by Dr. Congxin Huang, in the Cardiovascular Research Institute at Wuhan University in China, reports that treatment with a β-receptor antagonist abolishes cardiac arrythmias in […]
SAN DIEGO, May 21, 2018 /PRNewswire/ — Viera BioScience announced today positive data demonstrating that its AngioMune™ T Regulatory Cell based product successfully reduced cardiac damage and stimulated production of new blood vessels in animals that were induced to undergo a heart attack. The use of T regulatory cells for angiogenesis is […]
PARIS, May 22, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced 30-day data demonstrating that treatment with the Edwards SAPIEN 3 valve in more than 450 commercial centers around the U.S. show consistently positive patient outcomes. The […]
PARIS, May 22, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced five-year results from the FAME 2 study, which showed that patients had fewer major adverse cardiac events (MACE) when they received a heart stent guided by Abbott’s fractional flow reserve (FFR) diagnostic tool in combination with medical therapy compared to patients […]
